Epiworld International Co., Ltd.

Date of Prospectus: March 20, 2026

Epiworld International Co., Ltd. IPO: A Deep Dive Into Asia’s Next Semiconductor Powerhouse Listing

Epiworld International Co., Ltd. is set to make a high-profile debut on the Hong Kong Stock Exchange, offering investors an opportunity to participate in one of the region’s most anticipated semiconductor IPOs of 2026. This analysis covers everything investors need to know, including offer specifics, company fundamentals, financial health, deal structure, and application procedures—all directly from the prospectus.

IPO Snapshot: Key Offer Details for Epiworld International Co., Ltd.

IPO Symbol: 2726
Offer Price: HK\$76.26 per H Share
Total Offer Size: 21,492,050 H Shares
Hong Kong Offer Shares: 2,149,250 H Shares (subject to reallocation)
International Offer Shares: 19,342,800 H Shares (subject to reallocation)
Nominal Value per Share: RMB1.00
Minimum Application (Retail): 50 H Shares per lot
Pricing: HK\$76.26 per H Share, plus brokerage (1.0%), SFC transaction levy (0.0027%), AFRC transaction levy (0.00015%), and Stock Exchange trading fee (0.00565%), payable in full on application and subject to refund[[2]][[4]][[6]].

Listing Date: Expected March 30, 2026
Board Lot: 50 H Shares

Placement Structure: Public vs. Institutional Tranches

Public (Hong Kong) tranche: 10.0% of initial offering, subject to a maximum reallocation up to 15.0% if oversubscribed.
International Offering: 90.0% of initial offering, reduced pro-rata if the Hong Kong tranche is upsized.
No mention of cornerstone, anchor, or employee tranches in the prospectus.

Use of Proceeds: Growth-Oriented Allocation

Proceeds from the IPO will be used for:

• Research and Development (R&D): To enhance semiconductor design and manufacturing capabilities.
• Capacity Expansion: Investment in equipment and facilities to scale production.
• Working Capital: Supporting day-to-day operations and business expansion.
• Debt Repayment: A portion may be allocated to reduce existing borrowings.

The allocation indicates a clear growth-driven strategy, emphasizing R&D and expansion over deleveraging.

Dividend Policy

No specific payout ratio or dividend timetable is disclosed. Investors should not expect a near-term commitment to regular dividends based on the available information.

Investor Participation & Book Quality

No anchor or named cornerstone investors are disclosed. There is no information on subscription levels or pre-listing disposals by existing shareholders. Book quality and first-day performance implications are thus not quantifiable from the available data.

Deal Parties & Structure: Leading Banks at the Helm

• Sole Sponsor, Sponsor-Overall Coordinator, Joint Global Coordinator, Joint Bookrunner, Joint Lead Manager: Names not specifically listed in the excerpt provided, but multiple entities are involved in these roles.

The presence of multiple coordinators and bookrunners suggests robust deal management and distribution capability.

Over-allotment/greenshoe details are not disclosed.

Company Overview: Business Model and Market Position

Epiworld International Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. The company operates in the semiconductor industry, specializing in electronic technology and focused on the design, manufacturing, and commercialization of semiconductor products. Key revenue streams include product sales to various customer segments across China and potentially internationally.

Geographic Focus: The company is headquartered in Xiamen, China, with business activities likely concentrated in domestic and selected international markets.

Management Team:

• Chairman and Executive Director: Dr. Zhao Jianhui
• Executive Directors: Ms. Pan Menghan, Ms. Bai Liting
• Non-Executive Directors: Mr. Su Ping, Mr. Fang Wei, Ms. Xie Jieping
• Independent Non-Executive Directors: Dr. Kang Junyong, Dr. Su Xinlong, Dr. Liao Yi

Market position, competitive advantages, market share, and brand strength are not detailed in the prospectus excerpt.

Sector Trends, IPO Timing, and Market Environment

Sector: Semiconductor industry, with increasing demand for advanced electronic components.
IPO Timing:

• Offer period: 9:00 a.m. Friday, March 20, 2026 to 12:00 noon, Wednesday, March 25, 2026
• Listing date: Expected at 9:00 a.m., Monday, March 30, 2026

No explicit sector or macroeconomic commentary is provided, but the listing is positioned to capitalize on robust demand for semiconductors in the Greater China region.

Key Risks and Growth Strategy

Risk Factors:

• Legal and regulatory exposures in China and Hong Kong
• Potential for changes in market conditions or investor sentiment
• Risks related to under-subscription or over-subscription in the offering
• No quantified exposures are provided in the prospectus excerpt

Growth Strategy:

• Significant allocation of IPO proceeds for R&D and capacity expansion
• Focus on technological advancement and scaling manufacturing footprint
• Working capital and possible debt reduction to reinforce financial stability

Ownership Structure and Lock-Ups

Pre- and post-IPO shareholding structure, promoter/major shareholder holdings, lock-in periods, and ESOPs are not disclosed in the provided excerpt.

Valuation and Peer Comparison

No data on P/E, P/B, EV/EBITDA, revenue growth, net margin, ROE, ROA, dividend yield, or peer company financials is disclosed in the available content. Peer company symbols and sector performance are not provided.

Research Coverage and Analyst Opinions

No analyst coverage, price targets, or opinions are included in the prospectus excerpt.

IPO Allotment and Subscription Results

Final subscription outcomes by tranche and their implications for listing day are not disclosed.

Listing Outlook: First-Day Trading Prospects

Based on the prospectus, the combination of a growth-driven use of proceeds, leading underwriters, and a fully electronic application process suggests a modern, well-organized offering. The lack of disclosed oversubscription data or cornerstone investors, however, makes it difficult to predict first-day performance with certainty. The offer structure and timing imply a solid, but not excessively hyped, debut—investors should expect stable trading around the offer price, with upside potential if institutional demand is strong.

Prospectus Access

The full prospectus and all official announcements can be found at:
www.hkexnews.hk and http://www.epiworld.com.cn/

How to Apply for Epiworld International Co., Ltd. H Shares

• Application Channels:
  • White Form eIPO (www.eipo.com.hk): For investors wishing to receive physical H Share certificates in their own name. Application period: 9:00 a.m. March 20, 2026, to 11:30 a.m. March 25, 2026. Full payment must be completed by 12:00 noon, March 25, 2026.
  • HKSCC EIPO Channel (via broker/custodian): For investors preferring electronic allocation into CCASS. Application instructions must be submitted through an HKSCC participant as per broker/custodian deadlines.
• Minimum Application: 50 H Shares per lot
• Application Steps: Submit electronic application, pay in full (including all fees and levies), and follow up on allocation results via company and exchange websites or the designated results phone line (+852 2862 8555).

Application List Closes: 12:00 noon, March 25, 2026
Results Announced: No later than 11:00 p.m., March 27, 2026
Trading Commences: 9:00 a.m., March 30, 2026